☰

David W. Salzman, Ph.D. - Publications

Affiliations: 
Gatehouse Bio 
Area:
RNA, microRNA, molecular biology, genetics, radiation therapy, translational science
Tree Info Grants Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jung SY, Malhotra P, Nguyen KC, Salzman D, Qi Y, Pak EH, King J, Vlashi E, Ann D, Weidhaas JB. The KRAS-variant and its impact on normal breast epithelial cell biology. Cell Death and Differentiation. PMID 30932013 DOI: 10.1038/S41418-019-0320-Y  0.615
2019 Weidhaas JB, Scheffler AW, Salzman D, Kalbasi A, Wilenius K, Rietdorf E, Heilig M, Pitka M, Desler C, Ruan D, Ribas A, Drakaki A, Scholz MC, Telesca D. A germline microRNA-based biomarker signature of immune-associated toxicity to anti-PD1/PDL1 therapy. Journal of Clinical Oncology. 37: 96-96. DOI: 10.1200/Jco.2019.37.8_Suppl.96  0.531
2017 Weidhaas JB, Telesca D, Kalbasi A, Salzman D, Ribas A. Germ-line biomarkers disrupting microRNA regulatory pathways to predict toxicity and response to anti-PD-1 and anti-PD-L1 therapies. Journal of Clinical Oncology. 35: 3040-3040. DOI: 10.1200/Jco.2017.35.15_Suppl.3040  0.567
2016 Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB. Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9. Non-Coding Rna. 2. PMID 29657269 DOI: 10.3390/Ncrna2040010  0.503
2016 Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB. The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding Rna. 2. PMID 29657267 DOI: 10.3390/Ncrna2030009  0.499
2016 Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ, Weidhaas JB. miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nature Communications. 7: 10954. PMID 26996824 DOI: 10.1038/Ncomms10954  0.602
2015 McVeigh TP, Jung SY, Kerin MJ, Salzman DW, Nallur S, Nemec AA, Dookwah M, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney KJ, Zelterman D, Sweasy J, et al. Estrogen withdrawal, increased breast cancer risk and the KRAS-variant. Cell Cycle (Georgetown, Tex.). 14: 2091-9. PMID 25961464 DOI: 10.1080/15384101.2015.1041694  0.627
2015 Weidhaas JB, McVeigh TP, Jung SY, Salzman D, Nallur S, Dookwah M, Nemec AA, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney KJ, Zelterman D, Sweasy J, et al. Estrogen withdrawal, breast cell transformation, and multiple breast cancer risk in women with the KRAS-variant. Journal of Clinical Oncology. 33: e12541-e12541. DOI: 10.1200/Jco.2015.33.15_Suppl.E12541  0.572
2014 Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouché O, Piessevaux H, Tejpar S. A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4499-510. PMID 25183481 DOI: 10.1158/1078-0432.CCR-14-0348  0.561
2014 Dorairaj JJ, Salzman DW, Wall D, Rounds T, Preskill C, Sullivan CA, Lindner R, Curran C, Lezon-Geyda K, McVeigh T, Harris L, Newell J, Kerin MJ, Wood M, Miller N, et al. A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer. Bmc Cancer. 14: 421. PMID 24915755 DOI: 10.1186/1471-2407-14-421  0.569
2013 Salzman DW, Weidhaas JB. SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacology & Therapeutics. 137: 55-63. PMID 22964086 DOI: 10.1016/j.pharmthera.2012.08.016  0.571
2011 Salzman DW, Weidhaas JB. miRNAs in the spotlight: Making 'silent' mutations speak up. Nature Medicine. 17: 934-5. PMID 21818091 DOI: 10.1038/nm0811-934  0.54
2009 Felice KM, Salzman DW, Shubert-Coleman J, Jensen KP, Furneaux HM. The 5' terminal uracil of let-7a is critical for the recruitment of mRNA to Argonaute2. The Biochemical Journal. 422: 329-41. PMID 19508234 DOI: 10.1042/BJ20090534  0.537
2007 Salzman DW, Shubert-Coleman J, Furneaux H. P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. The Journal of Biological Chemistry. 282: 32773-9. PMID 17724023 DOI: 10.1074/jbc.M705054200  0.576
Show low-probability matches.